2008
DOI: 10.1037/1045-3830.23.3.354
|View full text |Cite
|
Sign up to set email alerts
|

The current state of empirical support for the pharmacological treatment of selective mutism.

Abstract: This article reviews the current state of evidence for the psychopharmacological treatment of children diagnosed with selective mutism within the context of its link to social anxiety disorder. An increased focus on potential medication treatment for this disorder has resulted from significant monetary and resource limitations in typical practice, parental choice in utilizing treatment from medical personnel, and children who fail to respond to psychosocial interventions. A total of 21 publications within the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
12
0
1

Year Published

2011
2011
2013
2013

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 28 publications
(15 citation statements)
references
References 73 publications
0
12
0
1
Order By: Relevance
“…The value of VSM has been under‐recognized in reviews of selective mutism interventions because speed of change and economy of treatment have not been among the criteria. These outcomes are in contrast to much lower rates of success and duration of treatment (2‐12 months, with some notable exceptions) with contingency management or pharmacology, the only other interventions with promise (Carlson, Mitchell, & Segool, 2008). For example, Kehle et al (1990; Table 1) describe a child who had not spoken in school for 3 years.…”
Section: Rapid Learningmentioning
confidence: 90%
“…The value of VSM has been under‐recognized in reviews of selective mutism interventions because speed of change and economy of treatment have not been among the criteria. These outcomes are in contrast to much lower rates of success and duration of treatment (2‐12 months, with some notable exceptions) with contingency management or pharmacology, the only other interventions with promise (Carlson, Mitchell, & Segool, 2008). For example, Kehle et al (1990; Table 1) describe a child who had not spoken in school for 3 years.…”
Section: Rapid Learningmentioning
confidence: 90%
“…Studies that feature randomized single-case experimental design , that use robust statistical techniques to augment visual analysis (to improve evidence standards), and that include more settings for generalization (e.g., the community) are needed to demonstrate that psychosocial interventions are a viable alternative to pharmacological interventions when treating SM (Carlson et al, 2008). Further examination is also needed to solidify the link between anxiety and SM, specifically, how anxiety may be involved with the etiology of this disorder.…”
Section: Contributions Of This Study and Future Researchmentioning
confidence: 97%
“…However, it is important to note that although SM is rare and may not affect many students in the school setting; Carlson, Mitchell, and Segool (2008) noted that ''for comparison sake, the rate of selective mutism is slightly higher than the prevalence of autism (0.50%)' ' (p. 354).…”
mentioning
confidence: 97%
See 1 more Smart Citation
“…6 Moreover, as in Sara's case, pharmacotherapy is usually combined with psychosocial interventions, making it difficult to attribute improvement to one or the other treatment method. Nevertheless, the frequent association between selective mutism and social anxiety (a disorder that has been shown to be responsive to SSRIs in several large randomized controlled trials 7 ) and the findings of 2 systematic reviews on selective mutism 2,3 suggest that these medications merit consideration in this population, particularly when symptoms are severe and fail to remit in response to psychosocial interventions. The risks and benefits of medication must be carefully evaluated in each case against the risks and benefits of not pursuing medication (e.g., the risk of academic and social deterioration).…”
mentioning
confidence: 99%